Factors that Impact the Developability of Drug Candidates

The evaluation of developability mostly involves the integration of research activities in functional areas such as drug metabolism and pharmacokinetic (DMPK), pharmaceutical development, safety assessment, and process chemistry into drug discovery and development process in very early stages of dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Han, Chao, Wang, Binghe
Format: Buchkapitel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 18
container_issue
container_start_page 1
container_title
container_volume
creator Han, Chao
Wang, Binghe
description The evaluation of developability mostly involves the integration of research activities in functional areas such as drug metabolism and pharmacokinetic (DMPK), pharmaceutical development, safety assessment, and process chemistry into drug discovery and development process in very early stages of discovery. With the introductions to medicinal chemistry‐ and biotechnology‐based drug discovery and early development, it should be relatively easy to appreciate the complexities of the factors that may affect drug developability directly and indirectly for antibody‐drug conjugates (ADCs). It should be noted that process chemistry and biologics production are large functional areas that can have major impacts on a drug's developability. It is essential that collaboration with these areas is considered early on in order to define the best strategy for drug delivery.
doi_str_mv 10.1002/9781118833322.ch1
format Book Chapter
fullrecord <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_ebooks_10_1002_9781118833322_ch1_ch1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10.1002/9781118833322.ch1</sourcerecordid><originalsourceid>FETCH-LOGICAL-s1971-4fabaa3174a4fe2d952a29cae630334ae907d086c851721b1bb6b9e875a340423</originalsourceid><addsrcrecordid>eNpVj81KAzEUhSMiqLUP4C4vMDU3yeRnKVNrCwU37TrczNyxwdEpzaj07Z2iKC4O52dx4GPsFsQMhJB33joAcE4pJeWs3sEZu_4dyvO_Ytwlm-acopClM9JYe8X8AuuhP2Q-7HDgq9f9WMdMfE4f1PV7jKlLw5H3LZ8f3p95hW9NanCgfMMuWuwyTX98wraLh021LNZPj6vqfl1k8BYK3WJEVGA16pZk40uJ0tdIRgmlNJIXthHO1K4EKyFCjCZ6crZEpYWWasLg-_czdXQMFPv-JQcQ4QQf_sGHEf4k9QX3DEx3</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>book_chapter</recordtype></control><display><type>book_chapter</type><title>Factors that Impact the Developability of Drug Candidates</title><source>eBooks on EBSCOhost</source><creator>Han, Chao ; Wang, Binghe</creator><contributor>Wang, Binghe ; Siahaan, Teruna J ; Hu, Longqin</contributor><creatorcontrib>Han, Chao ; Wang, Binghe ; Wang, Binghe ; Siahaan, Teruna J ; Hu, Longqin</creatorcontrib><description>The evaluation of developability mostly involves the integration of research activities in functional areas such as drug metabolism and pharmacokinetic (DMPK), pharmaceutical development, safety assessment, and process chemistry into drug discovery and development process in very early stages of discovery. With the introductions to medicinal chemistry‐ and biotechnology‐based drug discovery and early development, it should be relatively easy to appreciate the complexities of the factors that may affect drug developability directly and indirectly for antibody‐drug conjugates (ADCs). It should be noted that process chemistry and biologics production are large functional areas that can have major impacts on a drug's developability. It is essential that collaboration with these areas is considered early on in order to define the best strategy for drug delivery.</description><identifier>ISBN: 1118833368</identifier><identifier>ISBN: 9781118833360</identifier><identifier>EISBN: 1118833325</identifier><identifier>EISBN: 9781118833322</identifier><identifier>DOI: 10.1002/9781118833322.ch1</identifier><language>eng</language><publisher>Hoboken, NJ: John Wiley &amp; Sons, Inc</publisher><subject>antibody‐drug conjugates ; Developability ; Drug ; drug delivery ; drug developability ; drug discovery ; drug metabolism ; Factors</subject><ispartof>Drug Delivery, 2016, p.1-18</ispartof><rights>Copyright © 2016 John Wiley &amp; Sons, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>779,780,784,793,24781,27925</link.rule.ids></links><search><contributor>Wang, Binghe</contributor><contributor>Siahaan, Teruna J</contributor><contributor>Hu, Longqin</contributor><creatorcontrib>Han, Chao</creatorcontrib><creatorcontrib>Wang, Binghe</creatorcontrib><title>Factors that Impact the Developability of Drug Candidates</title><title>Drug Delivery</title><description>The evaluation of developability mostly involves the integration of research activities in functional areas such as drug metabolism and pharmacokinetic (DMPK), pharmaceutical development, safety assessment, and process chemistry into drug discovery and development process in very early stages of discovery. With the introductions to medicinal chemistry‐ and biotechnology‐based drug discovery and early development, it should be relatively easy to appreciate the complexities of the factors that may affect drug developability directly and indirectly for antibody‐drug conjugates (ADCs). It should be noted that process chemistry and biologics production are large functional areas that can have major impacts on a drug's developability. It is essential that collaboration with these areas is considered early on in order to define the best strategy for drug delivery.</description><subject>antibody‐drug conjugates</subject><subject>Developability</subject><subject>Drug</subject><subject>drug delivery</subject><subject>drug developability</subject><subject>drug discovery</subject><subject>drug metabolism</subject><subject>Factors</subject><isbn>1118833368</isbn><isbn>9781118833360</isbn><isbn>1118833325</isbn><isbn>9781118833322</isbn><fulltext>true</fulltext><rsrctype>book_chapter</rsrctype><creationdate>2016</creationdate><recordtype>book_chapter</recordtype><sourceid/><recordid>eNpVj81KAzEUhSMiqLUP4C4vMDU3yeRnKVNrCwU37TrczNyxwdEpzaj07Z2iKC4O52dx4GPsFsQMhJB33joAcE4pJeWs3sEZu_4dyvO_Ytwlm-acopClM9JYe8X8AuuhP2Q-7HDgq9f9WMdMfE4f1PV7jKlLw5H3LZ8f3p95hW9NanCgfMMuWuwyTX98wraLh021LNZPj6vqfl1k8BYK3WJEVGA16pZk40uJ0tdIRgmlNJIXthHO1K4EKyFCjCZ6crZEpYWWasLg-_czdXQMFPv-JQcQ4QQf_sGHEf4k9QX3DEx3</recordid><startdate>20160506</startdate><enddate>20160506</enddate><creator>Han, Chao</creator><creator>Wang, Binghe</creator><general>John Wiley &amp; Sons, Inc</general><scope/></search><sort><creationdate>20160506</creationdate><title>Factors that Impact the Developability of Drug Candidates</title><author>Han, Chao ; Wang, Binghe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s1971-4fabaa3174a4fe2d952a29cae630334ae907d086c851721b1bb6b9e875a340423</frbrgroupid><rsrctype>book_chapters</rsrctype><prefilter>book_chapters</prefilter><language>eng</language><creationdate>2016</creationdate><topic>antibody‐drug conjugates</topic><topic>Developability</topic><topic>Drug</topic><topic>drug delivery</topic><topic>drug developability</topic><topic>drug discovery</topic><topic>drug metabolism</topic><topic>Factors</topic><toplevel>online_resources</toplevel><creatorcontrib>Han, Chao</creatorcontrib><creatorcontrib>Wang, Binghe</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Chao</au><au>Wang, Binghe</au><au>Wang, Binghe</au><au>Siahaan, Teruna J</au><au>Hu, Longqin</au><format>book</format><genre>bookitem</genre><ristype>CHAP</ristype><atitle>Factors that Impact the Developability of Drug Candidates</atitle><btitle>Drug Delivery</btitle><date>2016-05-06</date><risdate>2016</risdate><spage>1</spage><epage>18</epage><pages>1-18</pages><isbn>1118833368</isbn><isbn>9781118833360</isbn><eisbn>1118833325</eisbn><eisbn>9781118833322</eisbn><abstract>The evaluation of developability mostly involves the integration of research activities in functional areas such as drug metabolism and pharmacokinetic (DMPK), pharmaceutical development, safety assessment, and process chemistry into drug discovery and development process in very early stages of discovery. With the introductions to medicinal chemistry‐ and biotechnology‐based drug discovery and early development, it should be relatively easy to appreciate the complexities of the factors that may affect drug developability directly and indirectly for antibody‐drug conjugates (ADCs). It should be noted that process chemistry and biologics production are large functional areas that can have major impacts on a drug's developability. It is essential that collaboration with these areas is considered early on in order to define the best strategy for drug delivery.</abstract><cop>Hoboken, NJ</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1002/9781118833322.ch1</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISBN: 1118833368
ispartof Drug Delivery, 2016, p.1-18
issn
language eng
recordid cdi_wiley_ebooks_10_1002_9781118833322_ch1_ch1
source eBooks on EBSCOhost
subjects antibody‐drug conjugates
Developability
Drug
drug delivery
drug developability
drug discovery
drug metabolism
Factors
title Factors that Impact the Developability of Drug Candidates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T00%3A21%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=bookitem&rft.atitle=Factors%20that%20Impact%20the%20Developability%20of%20Drug%20Candidates&rft.btitle=Drug%20Delivery&rft.au=Han,%20Chao&rft.date=2016-05-06&rft.spage=1&rft.epage=18&rft.pages=1-18&rft.isbn=1118833368&rft.isbn_list=9781118833360&rft_id=info:doi/10.1002/9781118833322.ch1&rft_dat=%3Cwiley%3E10.1002/9781118833322.ch1%3C/wiley%3E%3Curl%3E%3C/url%3E&rft.eisbn=1118833325&rft.eisbn_list=9781118833322&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true